Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Endurance training remodels skeletal muscle phospholipid composition and increases intrinsic mitochondrial respiration in men with type 2 diabetes.

Pino MF, Stephens NA, Eroshkin AM, Yi F, Hodges A, Cornnell HH, Pratley RE, Smith SR, Wang M, Han X, Coen PM, Goodpaster BH, Sparks LM.

Physiol Genomics. 2019 Oct 7. doi: 10.1152/physiolgenomics.00014.2019. [Epub ahead of print]

PMID:
31588872
2.

Disruptions to the limb muscle core molecular clock coincide with changes in mitochondrial quality control following androgen depletion.

Rossetti ML, Esser KA, Lee C, Tomko RJ Jr, Eroshkin AM, Gordon BS.

Am J Physiol Endocrinol Metab. 2019 Oct 1;317(4):E631-E645. doi: 10.1152/ajpendo.00177.2019. Epub 2019 Jul 30.

PMID:
31361545
3.

The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.

Yao J, Chen Y, Nguyen DT, Thompson ZJ, Eroshkin AM, Nerlakanti N, Patel AK, Agarwal N, Teer JK, Dhillon J, Coppola D, Zhang J, Perera R, Kim Y, Mahajan K.

Sci Rep. 2019 Jul 4;9(1):9715. doi: 10.1038/s41598-019-46064-4.

4.

Arrdc2 and Arrdc3 elicit divergent changes in gene expression in skeletal muscle following anabolic and catabolic stimuli.

Gordon BS, Rossetti ML, Eroshkin AM.

Physiol Genomics. 2019 Jun 1;51(6):208-217. doi: 10.1152/physiolgenomics.00007.2019. Epub 2019 Apr 19.

PMID:
31002587
5.

Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.

Nerlakanti N, Yao J, Nguyen DT, Patel AK, Eroshkin AM, Lawrence HR, Ayaz M, Kuenzi BM, Agarwal N, Chen Y, Gunawan S, Karim RM, Berndt N, Puskas J, Magliocco AM, Coppola D, Dhillon J, Zhang J, Shymalagovindarajan S, Rix U, Kim Y, Perera R, Lawrence NJ, Schonbrunn E, Mahajan K.

Mol Cancer Ther. 2018 Dec;17(12):2796-2810. doi: 10.1158/1535-7163.MCT-18-0602. Epub 2018 Sep 21.

PMID:
30242092
6.

Exercise Response Variations in Skeletal Muscle PCr Recovery Rate and Insulin Sensitivity Relate to Muscle Epigenomic Profiles in Individuals With Type 2 Diabetes.

Stephens NA, Brouwers B, Eroshkin AM, Yi F, Cornnell HH, Meyer C, Goodpaster BH, Pratley RE, Smith SR, Sparks LM.

Diabetes Care. 2018 Oct;41(10):2245-2254. doi: 10.2337/dc18-0296. Epub 2018 Aug 2.

PMID:
30072402
7.

REDD1 induction regulates the skeletal muscle gene expression signature following acute aerobic exercise.

Gordon BS, Steiner JL, Rossetti ML, Qiao S, Ellisen LW, Govindarajan SS, Eroshkin AM, Williamson DL, Coen PM.

Am J Physiol Endocrinol Metab. 2017 Dec 1;313(6):E737-E747. doi: 10.1152/ajpendo.00120.2017. Epub 2017 Sep 12.

8.

Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.

Pauthner M, Havenar-Daughton C, Sok D, Nkolola JP, Bastidas R, Boopathy AV, Carnathan DG, Chandrashekar A, Cirelli KM, Cottrell CA, Eroshkin AM, Guenaga J, Kaushik K, Kulp DW, Liu J, McCoy LE, Oom AL, Ozorowski G, Post KW, Sharma SK, Steichen JM, de Taeye SW, Tokatlian T, Torrents de la Peña A, Butera ST, LaBranche CC, Montefiori DC, Silvestri G, Wilson IA, Irvine DJ, Sanders RW, Schief WR, Ward AB, Wyatt RT, Barouch DH, Crotty S, Burton DR.

Immunity. 2017 Jun 20;46(6):1073-1088.e6. doi: 10.1016/j.immuni.2017.05.007.

9.

Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3.

Dang J, Tiwari SK, Lichinchi G, Qin Y, Patil VS, Eroshkin AM, Rana TM.

Cell Stem Cell. 2016 Aug 4;19(2):258-265. doi: 10.1016/j.stem.2016.04.014. Epub 2016 May 6.

10.

bNAber: database of broadly neutralizing HIV antibodies.

Eroshkin AM, LeBlanc A, Weekes D, Post K, Li Z, Rajput A, Butera ST, Burton DR, Godzik A.

Nucleic Acids Res. 2014 Jan;42(Database issue):D1133-9. doi: 10.1093/nar/gkt1083. Epub 2013 Nov 7.

11.

Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome.

Ng BG, Hackmann K, Jones MA, Eroshkin AM, He P, Wiliams R, Bhide S, Cantagrel V, Gleeson JG, Paller AS, Schnur RE, Tinschert S, Zunich J, Hegde MR, Freeze HH.

Am J Hum Genet. 2012 Apr 6;90(4):685-8. doi: 10.1016/j.ajhg.2012.02.010. Epub 2012 Mar 22.

12.

Structural determinants of limited proteolysis.

Kazanov MD, Igarashi Y, Eroshkin AM, Cieplak P, Ratnikov B, Zhang Y, Li Z, Godzik A, Osterman AL, Smith JW.

J Proteome Res. 2011 Aug 5;10(8):3642-51. doi: 10.1021/pr200271w. Epub 2011 Jul 8.

13.

Structural and kinetic determinants of protease substrates.

Timmer JC, Zhu W, Pop C, Regan T, Snipas SJ, Eroshkin AM, Riedl SJ, Salvesen GS.

Nat Struct Mol Biol. 2009 Oct;16(10):1101-8. doi: 10.1038/nsmb.1668. Epub 2009 Sep 20.

14.

Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis.

Shiryaev SA, Remacle AG, Savinov AY, Chernov AV, Cieplak P, Radichev IA, Williams R, Shiryaeva TN, Gawlik K, Postnova TI, Ratnikov BI, Eroshkin AM, Motamedchaboki K, Smith JW, Strongin AY.

J Biol Chem. 2009 Oct 30;284(44):30615-26. doi: 10.1074/jbc.M109.041244. Epub 2009 Sep 2.

15.

Mutations in fd phage major coat protein modulate affinity of the displayed peptide.

Kuzmicheva GA, Jayanna PK, Eroshkin AM, Grishina MA, Pereyaslavskaya ES, Potemkin VA, Petrenko VA.

Protein Eng Des Sel. 2009 Oct;22(10):631-9. doi: 10.1093/protein/gzp043. Epub 2009 Jul 25.

16.

PMAP: databases for analyzing proteolytic events and pathways.

Igarashi Y, Heureux E, Doctor KS, Talwar P, Gramatikova S, Gramatikoff K, Zhang Y, Blinov M, Ibragimova SS, Boyd S, Ratnikov B, Cieplak P, Godzik A, Smith JW, Osterman AL, Eroshkin AM.

Nucleic Acids Res. 2009 Jan;37(Database issue):D611-8. doi: 10.1093/nar/gkn683. Epub 2008 Oct 8.

17.

A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.

Bazhan SI, Karpenko LI, Lebedev LR, Uzhachenko RV, Belavin PA, Eroshkin AM, Ilyichev AA.

Mol Immunol. 2008 Feb;45(3):661-9. Epub 2007 Sep 14.

PMID:
17869341
18.

CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1.

Karpenko LI, Bazhan SI, Eroshkin AM, Lebedev LR, Uzhachenko RV, Nekrasova NA, Plyasunova OA, Belavin PA, Seregin SV, Danilyuk NK, Danilenko ED, Zaitsev BN, Masicheva VI, Ilyichev AA, Sandakhchiev LS.

Dokl Biochem Biophys. 2007 Mar-Apr;413:65-7. No abstract available.

PMID:
17546955
19.

Combined virus-like particle-based polyepitope DNA/protein HIV-1 vaccine design, immunogenicity and toxicity studies.

Karpenko LI, Ilyichev AA, Eroshkin AM, Lebedev LR, Uzhachenko RV, Nekrasova NA, Plyasunova OA, Belavin PA, Seregin SV, Danilyuk NK, Zaitsev BN, Danilenko ED, Masycheva VI, Bazhan SI.

Vaccine. 2007 May 22;25(21):4312-23. Epub 2007 Mar 7.

PMID:
17418918
20.

WebProAnalyst: an interactive tool for analysis of quantitative structure-activity relationships in protein families.

Ivanisenko VA, Eroshkin AM, Kolchanov NA.

Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W99-104.

21.

[Construction of original artificial immunogens--candidate vaccines against HIV-1].

Lebedev LR, Gileva IP, Karpenko LI, Eroshkin AM.

Mol Gen Mikrobiol Virusol. 2000;(3):36-40. Russian.

PMID:
10975080
22.

Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble.

Karpenko LI, Ivanisenko VA, Pika IA, Chikaev NA, Eroshkin AM, Veremeiko TA, Ilyichev AA.

Amino Acids. 2000;18(4):329-37.

PMID:
10949916
23.

[Analysis of foreign epitopes inserted in HBcAG. Possible routes for solving the problem of chimeric core particle self assembly].

Karpenko LI, Ivanisenko VA, Pika IS, Chikaev NA, Eroshkin AM, Melamed NV, Veremeĭko TA, Il'ichev AA.

Mol Biol (Mosk). 2000 Mar-Apr;34(2):223-9. Russian. No abstract available.

PMID:
10779948
24.

[Search for sites containing functionally important substitutions in series of related or mutant proteins].

Ivanisenko VA, Eroshkin AM.

Mol Biol (Mosk). 1997 Sep-Oct;31(5):880-7. Russian. No abstract available.

PMID:
9454074
25.

ProMSED: protein multiple sequence editor for Windows 3.11/95.

Frolov AS, Pika IS, Eroshkin AM.

Comput Appl Biosci. 1997 Jun;13(3):243-8.

PMID:
9183528
26.

[Use of a phage peptide library in mapping the group-specific hemagglutinating domain of alpha-virus glycoprotein E2].

Kuz'micheva GA, Kuvshinov VN, Razumov IA, Ivanisenko VA, Eroshkin AM, Mishin VP, Ushakova TA, Loktev VB, Il'ichev AA.

Mol Gen Mikrobiol Virusol. 1997;(4):25-9. Russian.

PMID:
9411217
27.

[Localization of a group-specific, hemagglutinating epitope of alphavirus glycoprotein E2 using a phage peptide library].

Kuz'micheva GA, Kuvshinov VN, Razumov IA, Ivanisenko VA, Eroshkin AM, Mishin VP, Oreshkova SF, Loktev VB, Il'ichev AA, Sandakhchiev LS.

Dokl Akad Nauk. 1997 Jan;352(1):113-6. Russian. No abstract available.

PMID:
9102093
28.

[Cloning proviral DNA sequences of the human T-cell leukemia virus (HTLV-1) from the genome of cultured MT-4 cells].

Susloparov MA, Krendel'shchikov AV, Bakhtina MM, Bedristov AI, Babkin IV, Gutorov VV, Eroshkin AM, Mamaeva OA.

Mol Gen Mikrobiol Virusol. 1996 Apr-Jun;(2):32-9. Russian.

PMID:
8927062
29.

Design of immunogens as components of a new generation of molecular vaccines.

Loktev VB, Ilyichev AA, Eroshkin AM, Karpenko LI, Pokrovsky AG, Pereboev AV, Svyatchenko VA, Ignat'ev GM, Smolina MI, Melamed NV, Lebedeva CD, Sandakhchiev LS.

J Biotechnol. 1996 Jan 26;44(1-3):129-37.

PMID:
8717396
30.

Design of four-helix bundle protein as a candidate for HIV vaccine.

Eroshkin AM, Karginova EA, Gileva IP, Lomakin AS, Lebedev LR, Kamyinina TP, Pereboev AV, Ignat'ev GM.

Protein Eng. 1995 Feb;8(2):167-73.

PMID:
7543204
31.
32.

[Preparation of a mutant human tumor necrosis factor with increased resistance to proteases].

Korepanova AV, Eroshkin AM, Ivanisenko VA, Lebedev LR, Mikriukov NN, Pustoshilova NM, Petrenko VA, Il'ichev AA.

Mol Biol (Mosk). 1994 Jan-Feb;28(1):143-9. Russian.

PMID:
8145742
33.

Artificial protein vaccines with predetermined tertiary structure: application to anti-HIV-1 vaccine design.

Eroshkin AM, Zhilkin PA, Shamin VV, Korolev S, Fedorov BB.

Protein Eng. 1993 Nov;6(8):997-1001.

PMID:
7508628
34.
35.

[Design of four-helix protein--a possible vaccine against human immunodeficiency virus (HIV-1)].

Eroshkin AM, Zhilkin PA, Shamin VV.

Mol Biol (Mosk). 1993 May-Jun;27(3):538-51. Russian.

PMID:
7686249
36.

Inserting foreign peptides into the major coat protein of bacteriophage M13.

Ilyichev AA, Minenkova OO, Kishchenko GP, Tat'kov SI, Karpishev NN, Eroshkin AM, Ofitzerov VI, Akimenko ZA, Petrenko VA, Sandakhchiev LS.

FEBS Lett. 1992 Apr 27;301(3):322-4.

37.

[Directed reconstruction of the influenza virus hemagglutinin gene].

Petrenko VA, Kipriianov SM, Semenova LN, Boldyrev AN, Pozdniakov PI, Eroshkin AM, Sivolobova GF.

Mol Biol (Mosk). 1990 Sep-Oct;24(5):1230-40. Russian.

PMID:
2290420
38.

[Development of rules for vaccine engineering based on the variability of peptide fragments in closely related proteins].

Eroshkin AM, Fomin VI, Zhilkin PA, Kulichkov VA.

Mol Biol (Mosk). 1990 May-Jun;24(3):638-48. Russian.

PMID:
2402233
39.

Protein fragment variability analysis and some principles of protein engineering of vaccines.

Eroshkin AM, Fomin VI, Zhilkin PA, Kulichkov VA.

Protein Eng. 1990 Apr;3(5):425-31.

PMID:
2349212
40.

[The use of filamentous phage M13 in protein engineering].

Il'ichev AA, Minenkova OO, Tat'kov SI, Karpyshev NN, Eroshkin AM, Ofitserov VI, Akimenko ZA, Petrenko VA, Sandakhchiev LS.

Mol Biol (Mosk). 1990 Mar-Apr;24(2):530-5. Russian.

PMID:
2362594
41.

[Construction and expression in Escherichia coli of a gene of hybrid hemagglutinin H1-H3 of influenza virus].

Petrenko VA, Kipriianov SM, Mizenko GA, Eroshkin AM, Sivolobova GF, Rukavishnikov MIu, Akimenko ZA, Boldyrev AN, Kalashnikov VV.

Mol Biol (Mosk). 1990 Mar-Apr;24(2):408-16. Russian.

PMID:
1694568
42.

[Production of a viable variant of the M13 phage with a foreign peptide inserted into the basic coat protein].

Il'ichev AA, Minenkova OO, Tat'kov SI, Karpyshev NN, Eroshkin AM, Petrenko VA, Sandakhchiev LS.

Dokl Akad Nauk SSSR. 1989;307(2):481-3. Russian. No abstract available.

PMID:
2806065
43.

[Primary structure of the mutant genes of human leukocyte interferon alpha2].

Petrenko VA, Tat'kov SI, Eroshkin AM, Boldyrev AN, Pozdniakov PI.

Bioorg Khim. 1988 Jun;14(6):810-4. Russian.

PMID:
3190769
44.
45.

[Structural and physico-chemical properties of amino acids of functionally important regions of proteins].

Eroshkin AM, Zhilkin PA, Popkov IK, Kulichkov VA.

Biofizika. 1987 Nov-Dec;32(6):972-81. Russian.

PMID:
3435721
46.

[A method of calculatiing immunochemical cross-reactions between homologous proteins].

Maksiutov AZ, Eroshkin AM, Kulichkov VA.

Mol Biol (Mosk). 1987 Jan-Feb;21(1):39-47. Russian.

PMID:
2437440
47.

[The nature of amino acid substitution in antigenic drift of hemagglutinin N3 and neuraminidase N2 from the influenza virus].

Eroshkin AM, Kulichkov VA.

Mol Biol (Mosk). 1986 Mar-Apr;20(2):546-57. Russian.

PMID:
2422540

Supplemental Content

Loading ...
Support Center